GLIMISAVE M1/850 (Glimepiride (1mg) + Metformin (850mg))

Glimisave M1 850 Tablet PR is classified as an anti-diabetic medication, specifically designed for managing type 2 diabetes mellitus in adults. This medication consists of a combination of two active ingredients that work together to help regulate blood sugar levels in individuals diagnosed with diabetes. For optimal results, it is recommended to take Glimisave M1 850 Tablet PR alongside food and to adhere to a consistent daily schedule. The prescribing physician will determine the most appropriate dosage for each patient, which may be adjusted periodically based on the effectiveness of treatment and current blood sugar measurements. It is crucial to continue the medication even if you feel well or your blood sugar appears stable, as discontinuing it without medical advice could lead to elevated blood sugar levels, posing serious health risks such as kidney damage, vision impairment, nerve issues, and limb loss. This medication should be considered a component of a comprehensive management plan that includes a balanced diet, regular physical activity, and weight management, as recommended by a healthcare provider. Lifestyle modifications play a significant role in maintaining diabetes control. One of the primary side effects associated with Glimisave M1 850 Tablet PR is hypoglycemia, characterized by lower-than-normal blood glucose levels. It is essential to understand the symptoms of hypoglycemia, which may include sweating, dizziness, headaches, and trembling, and to know how to respond appropriately. Regular meal intake and having a quick source of glucose on hand, such as candy or fruit juice, can help prevent these incidents. Caution is advised with alcohol consumption, as it may exacerbate the risk of low blood sugar levels. Other potential side effects include alterations in taste, nausea, diarrhea, abdominal discomfort, headaches, and respiratory infections. Weight gain may also be observed in some individuals taking this medication. Individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver issues should not use this medication. Prior to starting Glimisave M1 850 Tablet PR, it is important to inform your healthcare provider of any history of heart disease. Pregnant and breastfeeding women should speak with their physician to discuss the safety of this medication. Regular monitoring of blood glucose levels and possibly blood tests to assess blood cell counts and liver health may be necessary during treatment.